Drug ID: | NPD4084 |
Drug Name: | |
Molecular Formula: | C20H25N3O5 |
Canonical SMILES: | COc1ccc(cc1OC)CCNCCCNC(=O)c1ccc(cc1)N(=O)=O |
Standard InCHI: | InChI=1S/C20H25N3O5/c1-27-18-9-4-15(14-19(18)28-2)10-13-21-11-3-12-22-20(24)16-5-7-17(8-6-16)23(25)26/h4-9,14,21H,3,10-13H2,1-2H3,(H,22,24) |
Standard InCHIKey: | XEAKAKKNLOUHDV-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB015899 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 387.18 |
ALogP | -0.4963 |
MLogP | 2.78 |
XLogP | 3.427 |
HDA | 3 |
HBD | 2 |
Rotatable Bonds | 15 |
TPSA | 102.73 |
RO5 Violation | 1 |